Skip to main content

postdoc Jun Wang first co-author publishes in Nature Genetics “Histone H3 proline 16 hydroxylation regulates mammalian gene expression”

November 9, 2022

This publication is the result of collaboration with many researchers from UNC Biochemistry and Biophysics, Lineberger, University of Texas Southwestern, University of Edinburgh, Center for Epigenetics-Van Andel Institute, and Yale. First co-authors are Drs. Xijuan Liu and Jun Wang. Congratulations on your publication in Nature! Subjects: Breast cancer, Epigenetics, Gene Expression.

2022 BCBP Spring Seminar Series announced

January 18, 2022

— January 25 (Virtual) Elizabeth Kellogg, Ph.D., Assistant Professor, Dept. of Molecular Biology & Genetics Cornell University Host: Brian Kuhlman Title: Mechanistic studies of CRISPR-associated transposons (CAST) using cryo-EM   February 8 (Virtual) Peter Penzes, Ph.D., Director, Center for Autism and Neurodevelopment Northwestern University -Host: Patricia Maness Title: Synaptic biology of ankyrin   February 15 … Continued

BCBP Seminar: Lingjun Li (Univ. of WS-Madison)

December 2, 2021

Lingjun Li, Ph.D., Professor, Pharmaceutical Sciences and Chemistry, University of Wisconsin-Madison Venue: Zoom Talk Title: Advancing Biomedical Research via Innovation in Mass Spectrometry-based Approaches Host: Xian Chen

Student Thesis Defense: Astor Ankney

June 20, 2019

Thesis title: Secretotranscriptomics: A Novel Approach to the Discovery of Liquid Biopsy Biomarkers for Breast Cancer Prognosis Seminar is based upon the doctoral dissertation of Astor Ankney under the direction of Dr. Xian Chen ABSTRACT Presently, a 50-gene expression model (PAM50) serves as a breast cancer subtype classifier that is insufficient to distinguish, within each … Continued

Seminar: Bing Zhang, PhD (Baylor)

June 14, 2019

BING ZHANG, PHD ǀ Baylor College of Medicine                                                                                     Host: Xian Chen “Proteogenomics: A New Avenue for Cancer Research” Proteogenomics is a new research field at the interface of genomics and proteomics. In this talk, I will introduce our computational infrastructure and bioinformatics tools for cancer proteogenomic data analysis. Using proteogenomics data from the Clinical … Continued